Trade Summary

6 days ago, Lesage Anne, serving as Chief Early Development at Pharvaris N.V. (PHVS), sold 4,600 shares at $35.12 per share, for a total transaction value of $161,560.28. Following this transaction, Lesage Anne now holds 131,669 shares of PHVS.

This sale represents a 3.38% decrease in Lesage Anne's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, June 25, 2026 and publicly disclosed via SEC Form 4 filing on Monday, June 29, 2026 at 6:41 PM ET, 4 days after the trade was made.

Pharvaris N.V. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.